FOXP3 and breast cancer: Furthermore, eight studies provided HRs on OS and the pooled results showed that breast cancer patients in the high FOXP3+ TILs group were significantly associated with a poor OS (HR =1.447, 95 % CI [1.037–2.019], p = 0.030).